JOHN Y. TELEVANTOS

Corporate Board Profile

Tech Score: 0/100

← Back to All Directors

BALCHEM CORP

Filing Date Source Excerpt
2006-04-28 Dr. John Y. Televantos, age 53, has been a director since February 2005. ... The current members of the Compensation Committee are Messrs. McMillan, Mitchell, Dr. Televantos (Chair) and Dr. Wedral, each of whom are independent directors. ... The current members of the Executive Committee are Messrs. McMillan and Mitchell (Chair), and Dr. Televantos. ... The current members of the Corporate Governance & Nominating Committee are Messrs. Ammidon and Mitchell and Drs. Televantos and Wedral (Chair), all of whom are "independent" under AMEX listing standards. ... For 2005, the Company paid each of its directors, other than Mr. Rossi, an annual fee of $13,000 and $4,000 for each Board meeting attended. For fiscal 2005, the Company also paid to each of its directors serving on Committees the following fees, plus expenses, for each Committee meeting attended: Chairman of the Audit Committee, $2,500; Chairman of the Compensation Committee, $2,000; chairman of all other Committees, $1,500; all other Committee members, $1,000. The Lead Director is paid an additional $5,000 per year.
2007-04-27 Dr. John Y. Televantos, age 54, has been a Director since February 2005. ... The current members of the Compensation Committee are Messrs. McMillan, Mitchell, Dr. Televantos (Chair) and Dr. Wedral, each of whom are independent directors. ... The current members of the Executive Committee are Messrs. McMillan, Mitchell (Chair), and Dr. Televantos. ... The current members of the Corporate Governance & Nominating Committee are Messrs. Ammidon and Mitchell and Drs. Televantos and Wedral (Chair). ... The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company's directors (other than Mr. Rossi, whose compensation is set forth in the Summary Compensation Table above) during the fiscal year ended December 31, 2006. ... John Televantos $45,000 $115,560 - $160,560
2008-04-25 Dr. John Y. Televantos, age 55, has been a Director since February 2005. ... The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. McMillan and Mitchell, and Dr. Wedral, each of whom are independent directors. ... The current members of the Corporate Governance & Nominating Committee are Dr. Wedral (Chair), Messrs. Ammidon and Mitchell and Dr. Televantos. ... The current members of the Executive Committee are Messrs. McMillan, Mitchell (Chair), and Dr. Televantos.
2009-04-28 Dr. John Y. Televantos, age 56, has been a Director since February 2005...The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. McMillan and Mitchell, and Dr. Wedral...The current members of the Corporate Governance & Nominating Committee are Dr. Wedral (Chair), Messrs. Premdas and Mitchell and Dr. Televantos...The current members of the Executive Committee are Messrs. Mitchell (Chair), McMillan and Dr. Televantos...The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company's directors (other than Mr. Rossi, whose compensation is set forth in the Summary Compensation Table above) during the fiscal year ended December 31, 2008. John Televantos $57,667 Fees Earned or Paid in Cash, $109,863 Stock Awards, Total $167,530.
2010-04-30 Dr. John Y. Televantos, age 57, has been a director since February 2005. Dr. Televantos is a Principal of Arsenal Capital Partners, Inc., a private equity investment firm, where he leads the Chemicals and Materials practice of the firm. Dr. Televantos was formerly with Hercules, Inc. as President of the Aqualon Division and as Vice President of Hercules, Inc. from April 2002 through February 2005. He had been President and Chief Executive Officer, and prior to that Chief Operating Officer, of Foamex International Inc. during the period from June 1999 through December 2001. Prior to that, he was Vice President, Development Businesses and Research at Lyondell Chemical Company since 1998.
2011-04-28 Dr. John Y. Televantos, age 58, has been a director since February 2005. Dr. Televantos is a Partner at Arsenal Capital Partners, Inc. The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. Fischer, McMillan, and Dr. Wedral. The current members of the Corporate Governance and Nominating Committee are Dr. Wedral (Chair), Messrs. Premdas, Coombs and Dr. Televantos. The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan. Dr. Televantos has been the Lead Director since August of 2010. The Company pays each of its directors, other than Mr. Rossi, an annual retainer of $24,000 and $4,000 for each Board meeting attended, plus expenses. The Lead Director, Chairman of the Audit Committee and Chairman of the Compensation Committee are paid an additional $8,000 annual retainer fee. The Chairman of the Corporate Governance and Nominating Committee is paid an additional $6,000 annual retainer fee. The Company also pays to each of its directors serving on Committees a fee of $1,000, plus expenses, for each Committee meeting attended. The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company’s directors (other than Mr. Rossi) during the fiscal year ended December 31, 2010. John Televantos Fees Earned or Paid in Cash ($) 59,000 Stock Awards ($) 100,016 All Other Compensation ($) – Total ($) 162,264.
2012-04-27 Dr. John Y. Televantos, age 59, a Class 3 director whose current term expires 2014, has been a director since February 2005. ... Dr. Televantos is also significantly involved in private equity markets and processes involving chemical manufacturing companies. ... The current members of the Compensation Committee are Dr. Televantos (Chair), Messrs. Fischer, McMillan, and Dr. Wedral. ... The current members of the Corporate Governance and Nominating Committee are Dr. Wedral (Chair), Messrs. Premdas, Coombs and Dr. Televantos. ... The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan. ... Dr. Televantos has been the Lead Director since August of 2010. ... John Televantos: Fees Earned or Paid in Cash $66,000, Stock Awards $100,033, Total $166,033.
2014-05-01 Dr. John Y. Televantos, age 61, a Class 3 director whose current term expires in 2014, has been a director since February 2005, and lead director since August of 2010. ... The current members of the Compensation Committee are Dr. Televantos (Chair) and Messrs. Fischer and McMillan. ... The current members of the Corporate Governance and Nominating Committee are Messrs. McMillan (Chair), Premdas, and Coombs and Dr. Televantos. ... The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan. ... The Company pays each of its directors, other than Mr. Rossi, an annual retainer of $30,000 and $4,000 for each Board meeting attended, plus expenses. The Lead Director, Chairman is paid an additional $16,000 annual retainer fee. The Chairman of the Audit Committee, the Chairman of the Compensation Committee and the Chairman of the Corporate Governance and Nominating Committee are paid an additional $8,000 annual retainer fee. ... John Televantos $75,000 Fees Earned or Paid in Cash, $110,003 Stock Awards, Total $185,003.
2015-04-27 Dr. John Y. Televantos, age 62, a Class 3 director whose current term expires in 2017, has been a director since February 2005, and lead director since August 2010. The current members of the Compensation Committee are Dr. Televantos (Chair) and Messrs. Fischer and McMillan. The current members of the Corporate Governance and Nominating Committee are Messrs. McMillan (Chair), Premdas and Coombs and Dr. Televantos. The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan. The following table discloses the cash, equity awards, and other compensation earned, paid, or awarded, as the case may be, to each of the Company’s directors (other than Mr. Rossi) during the fiscal year ended December 31, 2014. John Televantos: $194,040.
2016-04-28 Dr. John Y. Televantos, age 63, a Class 3 director whose current term expires in 2017, has been a director since February 2005, and lead director since August 2010. ... The current members of the Compensation Committee are Dr. Televantos (Chair) and Messrs. Fischer and McMillan. ... The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan.
2018-05-01 Dr. John Y. Televantos, age 65, a Class 3 director whose current term expires in 2020, has been a director since February 2005, and lead director since August 2010. ... The current members of the Compensation Committee are Dr. Televantos (Chair) and Messrs. Fischer, McMillan and Wineinger. ... The current members of the Corporate Governance and Nominating Committee are Messrs. McMillan (Chair), Coombs, Premdas and Wineinger. ... The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. McMillan.
2019-04-29 Dr. John Y. Televantos, age 66, a Class 3 director whose current term expires in 2020, has been a director since February 2005, and lead director since August 2010. ... The current members of the Compensation Committee are Dr. Televantos (Chair) and Messrs. Fischer, Premdas and Wineinger, each of whom is independent, as such term is defined under the NASDAQ Marketplace Rules. ... The current members of the Corporate Governance and Nominating Committee are Messrs. Wineinger (Chair), Coombs, Premdas and Dr. Televantos, each of whom is independent, as such term is defined under the NASDAQ Marketplace Rules. ... The current members of the Executive Committee are Dr. Televantos (Chair), Mr. Fischer and Mr. Premdas.

Data sourced from SEC filings. Last updated: 2025-07-01